Symbiotic Healthcare, based in Manhattan, N.Y., has developed a capsule containing the processed fecal matter used in the C. difficile treatment fecal microbiota transplantation, according to a Crain's New York Business report.
Symbiotic Healthcare was founded by North Shore-LIJ Health System infectious disease specialist Bruce Hirsch, MD, and immunologist Gerard Honig. The company's capsule holds the processed matter and can be refrigerated for later use.
In a preliminary test including 23 patients, the pills resulted in an 87 percent cure rate.
The company is currently self-funded, but its founders are looking for financial backing, according to the report.
More Articles on Gastroenterology:
Hiring & firing: what gastroenterologists need to know about finding a stellar staff
Are C. diff infections on the move?
PPI is 3rd most-prescribed drug in the U.S.
Symbiotic Healthcare was founded by North Shore-LIJ Health System infectious disease specialist Bruce Hirsch, MD, and immunologist Gerard Honig. The company's capsule holds the processed matter and can be refrigerated for later use.
In a preliminary test including 23 patients, the pills resulted in an 87 percent cure rate.
The company is currently self-funded, but its founders are looking for financial backing, according to the report.
More Articles on Gastroenterology:
Hiring & firing: what gastroenterologists need to know about finding a stellar staff
Are C. diff infections on the move?
PPI is 3rd most-prescribed drug in the U.S.